Rowasa 1gm Pellets
Marketer
Abbott
Salt Composition
Mesalazine (1gm)
Overview Rowasa 1gm Pellets
Mesalamine 1g rectal pellets are an anti-inflammatory medication indicated for ulcerative colitis, a type of inflammatory bowel disease. This medication alleviates symptoms such as abdominal pain, rectal bleeding, and diarrhea by targeting intestinal inflammation. It may also be prescribed for Crohn's ileocolitis. Administer this medication with food, following your physician's precise instructions regarding dosage and duration of therapy. Premature discontinuation may result in symptom recurrence and disease exacerbation. Common side effects include nausea, abdominal discomfort, diarrhea, headache, pruritus, flatulence, and emesis. Report any persistent, worsening, or bothersome side effects to your doctor; management strategies may be available. Seek immediate medical attention for severe allergic reactions manifested by facial, lingual, or throat swelling; unusual bleeding or bruising; rash; fever; sore throat; or profound fatigue. Prior to initiating treatment, inform your doctor of any existing kidney or liver conditions, gastrointestinal obstructions, or pregnancy/breastfeeding status. Your age may influence treatment suitability. Disclose all concurrent medications, as interactions are possible.
Uses of Rowasa 1gm Pellets
Inflammatory bowel diseases, specifically ulcerative colitis and Crohn's disease
Major Benefits of Rowasa 1gm Pellets:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always refer to the product label for complete directions prior to administration. While Rowasa 1gm Pellets can be ingested with or without food, consistent timing is recommended for optimal results.
Common Side effects of Rowasa 1gm Pellets:
- Stomach pain/epigastric pain
- Flatulence
- Headache
- Vomiting
- Diarrhea
- Nausea
- Abdominal pain
- Rash
How to use Rowasa 1gm Pellets:
Follow your doctor's instructions precisely regarding dosage and treatment length. Always consult the product label for administration guidelines prior to use. Rowasa 1gm Pellets can be ingested with or without food; however, consistent timing is recommended.
How Rowasa 1gm Pellets works:
Mesalamine 1 gram rectal pellets, an aminosalicylate, act by inhibiting the synthesis of inflammatory prostaglandins within the intestinal tract. This mechanism lessens ulceration, bleeding, and abdominal discomfort, thereby mitigating subsequent disease exacerbations.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Rowasa 1gm Pellets and alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Rowasa 1gm Pellets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Mesalamine 1g suppositories may pose a risk to breastfeeding infants. Available data indicate potential drug transfer via breast milk, potentially harming the baby. Mothers using mesalamine 1g suppositories should observe their infants for diarrhea.
DrivingSAFE
Driving ability is typically unaffected by Rowasa 1gm suppositories.
KidneyCAUTION
Patients with kidney impairment should use Rowasa 1gm Pellets cautiously, potentially requiring dosage modification. Physician consultation is advised. Rowasa 1gm Pellets are contraindicated in patients with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Mesalamine 1g rectal granules cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Rowasa 1gm Pellets :
Should you forget a Rowasa 1gm Pellet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Rowasa 1gm Pellets
| Label | Value |
|---|---|
| Chemical Type | Salicylic Acid Derivative |
| Developing Good Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Mesalamine (5-ASA) |
3,018 People bought this recently